Company / Financials
ORTHOPEDIATRICS CORP Financials
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$148.7M
FY2025 · +21.6% YoY
Net Income
-$21.0M
FY2025 · -1767.2% YoY
Profit Margin
-14.1%
FY2025 · net income / revenue
ROE
-5.9%
FY2025 · return on equity
Total Assets
$508.6M
FY2025
Total Debt
$106.0M
0.30x debt/equity
Equity
$354.6M
FY2025
ROA
-4.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$148.7M+21.6% YoYNet Income HistoryProfit after all expenses and taxes-$21.0M-1767.2% YoYGross Profit HistoryRevenue minus cost of goods sold$111.3M+22.7% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$37.5M+18.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$26.8M-5.3% YoYSG&A Expense HistorySelling, general, and administrative expenses$73.3M+26.6% YoYR&D Expense HistoryResearch and development spending$10.9M+28.9% YoYInterest Expense HistoryCost of borrowing and debt obligations$42.0K-92.0% YoYIncome Tax HistoryTotal income tax expense-$338.0K+93.2% YoYEPS (Basic) HistoryBasic earnings per share-$0.92-1633.3% YoY